Pharmacists in Lexington, Kentucky
821 Pharmacists found in Lexington
Dr. Megan Cummins, PHARMD
Pharmacist
800 Rose St Rm H110, Lexington, KY 40536
859-323-4742 859-323-2049
Dr. Megan Michelle Peffer, PHARMD
Pharmacist
830 South Limestone, Lexington, KY 40536
859-257-6451 859-323-6898
Dr. Megan Christine Crepps, PHARMD, RPH
Pharmacist
1307 Winchester Rd, Lexington, KY 40505
859-254-4471
Dr. Melanie Mabins, PHARM.D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
217 Elm Tree Ln, Uk Healthcare Polk-dalton Clinic, Lexington, KY 40507
859-218-2802
Melanie Kyle Workman, RPH
Pharmacist
3001 Pink Pigeon Pkwy, Lexington, KY 40509
859-543-8665 859-543-0117
Dr. Melissa Looney, PHARM.D.,BCPS
Pharmacist - Pharmacotherapy
150 N Eagle Creek Dr, Lexington, KY 40509
859-967-5853 859-967-5522
Dr. Melissa Elizabeth Angell, PHARM.D.
Pharmacist - Pharmacotherapy
1101 Veterans Dr, Lexington, KY 40502
859-233-4511
Mrs. Melissa J Blackburn, RPH
Pharmacist
3120 Pimlico Pkwy, Park Hills Shopping Center, Lexington, KY 40517
869-273-7963
Dr. Melody Anne Ryan, PHARM.D.
Pharmacist - Pharmacotherapy
725 Rose St., Lexington, KY 40536
859-257-8790
Mr. Michael D Hislope, RPH
Pharmacist
1 Saint Joseph Dr, Lexington, KY 40504
859-313-4443 859-313-3070
Mr. Michael J Krupa, RPH
Pharmacist
3001 Pink Pigeon Pkwy, Lexington, KY 40509
859-543-8665 859-543-0117
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.